Nemluvio Side Effects: What to Expect and When to Call Your Doctor

Starting a new biologic medication naturally raises questions about side effects. Nemluvio (nemolizumab-ilto) has been studied in large clinical trials involving over 1,700 patients, giving us a clear picture of what to expect. Here's a straightforward breakdown of common and serious side effects — and the warning signs that should prompt a call to your doctor.

Is Nemluvio Safe? The Big Picture

Nemluvio has a favorable safety profile based on clinical trial data. It is not an immunosuppressant — it does not broadly suppress your immune system the way steroids or methotrexate do. Instead, it specifically blocks IL-31 receptor alpha, a targeted mechanism that limits its potential for systemic immune effects. There are no boxed warnings (the FDA's highest-level warning) for Nemluvio, which is reassuring compared to some other systemic treatments for eczema, such as JAK inhibitors.

Common Side Effects in Prurigo Nodularis Patients

These side effects were reported in 1% or more of patients treated for prurigo nodularis in the OLYMPIA 1 and OLYMPIA 2 clinical trials:

Headache — most common side effect in PN trials

Atopic dermatitis (eczema) flare — some PN patients who don't have pre-existing eczema may experience new eczematous skin reactions

Nummular eczema — round, coin-shaped patches of itchy rash; more common in patients 65 years and older

Common Side Effects in Atopic Dermatitis Patients

These side effects were reported in clinical trials for atopic dermatitis (ARCADIA 1 and ARCADIA 2):

Headache

Itchy rashes — can occur as a reaction separate from underlying AD

Nummular eczema — round patches of skin rash

Injection site reactions — mild redness, swelling, or discomfort at the injection site

Muscle and joint pain — myalgia and arthralgia have been reported

Serious Side Effects: When to Seek Emergency Care

Serious side effects were rare in Nemluvio's clinical trials. The primary serious adverse event to watch for is a hypersensitivity reaction (allergic reaction). Facial angioedema has been reported with Nemluvio use.

Stop using Nemluvio and seek emergency care immediately if you experience:

Swelling of the face, lips, tongue, or throat

Difficulty breathing or swallowing

Chest tightness or rapid heartbeat

Severe hives or widespread rash that worsens quickly

Dizziness, lightheadedness, or fainting

What About the "Eczema Flare" Side Effect — Is That Normal?

Yes, and it's an interesting phenomenon. Some patients taking Nemluvio for prurigo nodularis — a condition distinct from atopic dermatitis — develop new eczematous rashes. This is thought to occur because blocking IL-31 may shift the skin's inflammatory balance in ways that unmask underlying eczema-like reactivity. Similar reactions are also seen with other biologics targeting this pathway.

If you develop a new eczema-like rash while on Nemluvio, contact your dermatologist. It may be manageable with topical treatments and doesn't necessarily mean you need to stop Nemluvio. Your doctor can assess the extent and recommend an appropriate topical therapy.

Tips for Managing Injection Site Reactions

Allow Nemluvio to reach room temperature (30–45 minutes) before injecting — cold injections cause more discomfort

Rotate injection sites (thigh, abdomen, back of upper arm) to reduce localized reactions

Do not inject into skin that is bruised, scarred, red, or affected by psoriasis or rash

Finding Nemluvio After Side Effect Concerns

If side effects are manageable but you're having trouble obtaining refills, medfinder can help locate the specialty pharmacy that can fill your prescription. If you're unable to tolerate Nemluvio, see our guide on alternatives to Nemluvio to discuss other options with your dermatologist.